Wipro Limited Announces Results for the Quarter ended December 31, 2020 under IFRS
IT Services Revenue growth at 3.9% QoQ, highest in 36 quarters Net Income for the quarter increased by 20.8% YoY...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Hepatocellular Carcinoma Epidemiology Forecast to 2029: Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Hepatocellular Carcinoma - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The Hepatocellular Carcinoma (HCC)...
Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products Administration in China
Clinical trial expected to be initiated shortly after NMPA approval of the IND Sesen Bio to receive $3M milestone payment...
CSG Names Ken Kennedy Chief Operating Officer
DENVER--(BUSINESS WIRE)--CSG (NASDAQ: CSGS) today announced it has appointed Ken Kennedy as chief operating officer and president of its Revenue...
Microshare Expands Its Leadership Team as Global Client Base Expands Briskly
Microshare Announces New Executive Hires Phil Adams, Lauren Miller, Nadine North, Michael Moran 2020 Growth, led by Wearable Universal Contact...
APAC Kidney Disease Industry to 2027 – Increasing Incidences of ESRD (End-Stage Renal Disease) is Driving Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User;...
Genetron Health to Present at BTIG Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day on Jan. 22, 2021
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that...
City I&T Grand Challenge Invites Innovative Solutions From the Community for Smart Living Under New Normal
HONG KONG--(BUSINESS WIRE)--Organised by the Innovation and Technology Commission together with the Hong Kong Science and Technology Parks Corporation, the...
Asia-Pacific Active Insulation Market (2020 to 2026) – Key Motivators, Restraints and Opportunities – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Active Insulation Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific active insulation market is...
ComplyAdvantage Releases State Of Financial Crime Report For 2021
Designed as an must-have strategic roadmap for compliance teams, the comprehensive report covers financial crime insights related to fraud, cyber,...
Global 5G and Network Sharing Markets Study 2020 Featuring Three Advanced Use Cases in Europe and China – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "5G and Network Sharing - New Era, New Strategies" report has been added to ResearchAndMarkets.com's offering. This report...
Global 5G and Network Sharing Markets Study 2020 Featuring Three Advanced Use Cases in Europe and China – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "5G and Network Sharing - New Era, New Strategies" report has been added to ResearchAndMarkets.com's offering. This report...
Transformative Post-COVID-19 Trends and Growth Opportunities in ASEAN, 2020 Report – Focus on Singapore, Malaysia, Indonesia & Thailand – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Transformative Post-COVID-19 Trends and Growth Opportunities in ASEAN" report has been added to ResearchAndMarkets.com's offering. Macroeconomic Growth Opportunities...
Melbet India review
Melbet India The bookmaker Melbet began its work back in 2012. During this time, it managed to show itself from...
Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59
CT-P59 (40mg/kg) treated patients reported reduced progression rates to severe COVID-19 by 54% for patients with mild-to-moderate symptoms and 68%...
